Search Results - "FARHADI, Mohammed"

The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines by Jensen, Kenneth, Friborg, Jeppe, Hansen, Christian Rønn, Samsøe, Eva, Johansen, Jørgen, Andersen, Maria, Smulders, Bob, Andersen, Elo, Nielsen, Martin Skovmos, Eriksen, Jesper Grau, Petersen, Jørgen Breede Baltzer, Elstrøm, Ulrik Vindelev, Holm, Anne Ivalu, Farhadi, Mohammed, Morthorst, Morten Hjartdal, Skyt, Peter Sandegaard, Overgaard, Jens, Grau, Cai

Get full text

Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG PET/CT: A Single-Center Prospective Study by Risør, Louise M, Clausen, Malene M, Ujmajuridze, Zaza, Farhadi, Mohammed, Andersen, Kim F, Loft, Annika, Friborg, Jeppe, Kjaer, Andreas

“…The aim of this phase II clinical trial (NCT02965001) was to evaluate the prognostic value of urokinase-type plasminogen activator receptor (uPAR) PET/CT with…”
Get full text

Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18 F-FDG PET/CT: A Single-Center Prospective Study by Risør, Louise M, Clausen, Malene M, Ujmajuridze, Zaza, Farhadi, Mohammed, Andersen, Kim F, Loft, Annika, Friborg, Jeppe, Kjaer, Andreas

“…The aim of this phase II clinical trial (NCT02965001) was to evaluate the prognostic value of urokinase-type plasminogen activator receptor (uPAR) PET/CT with…”
Get full text

Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells by READ, Tracy-Ann, FARHADI, Mohammed, BJERKVIG, Rolf, OLSEN, Bjørn Reino, ROKSTAD, Anne Mari, HUSZTHY, Peter C, VAJKOCZY, Peter

“…The current study describes new, antivascular, and antitumor effects of human endostatin. A novel system for continuous, localized delivery of antiangiogenic…”
Get full text